pentobarbital has been researched along with Abnormalities, Drug-Induced in 9 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (88.89) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gomes-Carneiro, MR | 1 |
| De-Oliveira, AC | 1 |
| De-Carvalho, RR | 1 |
| Araujo, IB | 1 |
| Souza, CA | 1 |
| Kuriyama, SN | 1 |
| Paumgartten, FJ | 1 |
| GOLDMAN, AS | 1 |
| YAKOVAC, WC | 1 |
| Karpathios, T | 1 |
| Zervoudakis, A | 1 |
| Venieris, F | 1 |
| Parchas, S | 1 |
| Youroukos, S | 1 |
| Nishie, K | 1 |
| Gumbmann, MR | 1 |
| Keyl, AC | 1 |
| Marchetti, G | 1 |
| Wagener, HH | 1 |
| Eriksson, M | 2 |
| Milkovich, L | 1 |
| van den Berg, BJ | 1 |
| Giovanelli, L | 1 |
| Zanoni, A | 1 |
| Fregnan, L | 1 |
| Brandolin, P | 1 |
| Savorelli, M | 1 |
9 other studies available for pentobarbital and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Inhibition of cyclophosphamide-induced teratogenesis by beta-ionone.
Topics: Abnormalities, Drug-Induced; Animals; Body Weight; Cyclophosphamide; Cytochrome P-450 CYP2B1; Drug I | 2003 |
PREVENTION OF SALICYLATE TERATOGENICITY IN IMMOBILIZED RATS BY CERTAIN CENTRAL NERVOUS SYSTEM DEPRESSANTS.
Topics: Abnormalities, Drug-Induced; Central Nervous System Depressants; Chlorpromazine; Fetal Death; Immobi | 1964 |
Genetics and fetal hydantoin syndrome.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Anticonvulsants; Child; Child, Preschoo | 1989 |
Pharmacology of solanine.
Topics: Abdomen; Abnormalities, Drug-Induced; Animals; Anophthalmos; Cardiac Complexes, Premature; Central N | 1971 |
[Pharmacological and toxicological characterization of a multicomponent preparation in the treatment of circulatory disorders].
Topics: Abnormalities, Drug-Induced; Administration, Oral; Alkaloids; Animals; Blood Circulation; Dogs; Drug | 1974 |
Salicylate-induced foetal damage late in pregnancy. An experimental study in mice.
Topics: Abnormalities, Drug-Induced; Animals; Animals, Newborn; Aspirin; Carbon Isotopes; Coumarins; Female; | 1971 |
Effects of prenatal meprobamate and chlordiazepoxide hydrochloride on human embryonic and fetal development.
Topics: Abnormalities, Drug-Induced; Aluminum; Anxiety; Child, Preschool; Chlordiazepoxide; Embryo, Mammalia | 1974 |
Salicylate-induced foetal damage during late pregnancy in mice. The modifying effect of repeated administration and dosage.
Topics: Abnormalities, Drug-Induced; Animals; Chemical and Drug Induced Liver Injury; Female; Fetal Death; F | 1970 |
[Fetal abnormalities induced by anesthetic drugs in the early stages of pregnancy. Experimental study].
Topics: Abnormalities, Drug-Induced; Animals; Female; Gestational Age; Pentobarbital; Pregnancy; Propanidid; | 1969 |